G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/74 (2006.01)
Patent
CA 2688480
The use of fibroblast growth factor Fgf7 and of the corresponding receptor Fgfr2b as biomarker candidates for the progesterone receptor antagonist 11 .beta.-(4-acetylphenyl)- 17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafIuoroethyl)estra-4,9-dien-3-one, also known under the designations ZK230211 or ZK-PRA, of the Formula (I) and for antiestrogens is described.
L'invention porte sur l'utilisation du facteur de croissance des fibroblastes Fgf7 et du récepteur correspondant Fgfr2b en tant que candidats de biomarqueur pour l'antagoniste des récepteurs de la progestérone 11 .beta.-(4-acétylphényl)-17.beta.-hydroxy-17.alpha.-(1,1,2,2,2-pentafIuoroéthyl)estra-4,9-diène-3-one, également connu sous les dénominations ZK230211 ou ZK-PRA, représentée par la Formule (I) et pour des anti-AEstrogènes.
Hoffmann Jens
Korr Daniel
Kunde Jan
Sommer Anette
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Use of fibroblast growth factor 7 (fgf7) and of the receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of fibroblast growth factor 7 (fgf7) and of the receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of fibroblast growth factor 7 (fgf7) and of the receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1756649